VERIF·AI
Sign in Run a check
Home › Companies › Activities of other holding companies n.e.c. › Ingenox Therapeutics Limited

Ingenox Therapeutics Limited

Active ·14127227 ·Private Limited Company ·Est. 24 May 2022
5
Officers
Total Exemption Full
Accounts
⚠️
Initial checks flagged a potential issue. Further analysis recommended before making a decision.
COMPLIANCE SIGNAL
No accounts on record
47 months since incorporation
Confirmed from Companies House data Incorporated 24 May 2022
Full analysis checks for Ingenox Therapeutics Limited
  • 👤
    Director history and patterns Prior appointments, dissolved-company links, time-in-role across the cap table.
  • 📄
    Filing behaviour over time Lateness, restated accounts, confirmation-statement discipline across the last five years.
  • 📈
    Financial signals and trends Net assets, current liabilities, going-concern notes and year-on-year movement.
  • ✦
    Plain-English risk summary A clear paragraph telling you what these signals mean — and what to do about them.
Generated instantly from official filings and proprietary models.
🔒 Unlock the full report

Three ways to upgrade

If you check more than 2 companies a month, the £39 plan pays for itself.

  1. £99/mo · 30 Deep Dives Most popular
    £3.30 per report — the lowest rate
    Subscribe →
  2. £39/mo · 10 Deep Dives
    £3.90 per report — pays for itself after 2 reports
    Subscribe →
  3. £9 · 1 Deep Dive
    Single check, no subscription
    Buy £9 →

📊 Financial Snapshot

📄
Unstructured Filings Detected

Ingenox Therapeutics Limited submits accounts as unstructured PDF documents rather than digital XBRL.
Our AI engine securely extracts and restructures these PDFs into interactive financial dashboards in minutes.

Run Free Extraction

🏢 Company Details

Number14127227
StatusActive
TypePrivate Limited Company
Incorporated24 May 2022
IndustryActivities of other holding companies n.e.c.
SIC64209, 72110
AccountsTotal Exemption Full

📍 Registered Address

Magdalen Centre Robert Robinson Avenue
Oxford
OX4 4GA
United Kingdom

👤 Directors & Officers (5)

Prof Nicholas Barrie La ThangueDIRECTOR
David James KerrDIRECTOR
Leonard Stanley SenderDIRECTOR
Sandip Bobby ReddyDIRECTOR
Arnold James BanaagDIRECTOR

🔑 Persons with Significant Control (2)

Patrick Soon-Shiong50-75% shares
Prof Nicholas Barrie La Thangue75-100% shares

🏗️ Corporate Group & Network

🔽 2 subsidiaries 🔗 7 connected companies
Subsidiaries controlled by Ingenox Therapeutics Limited
Argonaut Therapeutics Limited75-100% shares Celleron Therapeutics Limited75-100% shares
Other companies sharing the same PSC
07633676via Patrick Soon-Shiong Celleron Therapeutics Limitedvia Prof Nicholas Barrie La Thangue 13423828via Prof Nicholas Barrie La Thangue Global Cancer Consultants Limitedvia Prof Nicholas Barrie La Thangue Argonaut Therapeutics Limitedvia Prof Nicholas Barrie La Thangue Directa Plus PLCvia Patrick Soon-Shiong Canivax Limitedvia Prof Nicholas Barrie La Thangue
Network data from Companies House PSC register · Full network analysis in Deep Dive →
Health Score
73
Revenue Trend
Risk Signals
🔒

AI Intelligence Report

Health score, risk analysis, compliance & sanctions screening

Go Deeper on Ingenox Therapeutics Limited

Our AI reads their filings so you don't have to — full balance sheet & P&L analysis, health score, director network intelligence, FCDO sanctions screening, and a narrative you can actually understand.

✓ Free · magic link login · ✓ AI-powered · ✓ Ready in ~2 min
10-Year Financials Health Score Risk Flags FCDO Sanctions PDF Export
Generate Deep Dive & Track Ingenox...
Sign up and generate a Deep Dive for full AI analysis, ratios, trend charts and automatic filing alerts.
Run full company check — £9